CONTRAD SWISS logo — We are devoted to improving people's life.

CONTRAD SWISS

We are devoted to improving people's life.

Founded 2011 Switzerland Lugano, Switzerland 17 employees Biotechnology, Manufacturing +2

General Information

Company Name CONTRAD SWISS
Founded Year 2011
Location Switzerland Lugano, Switzerland +1
Employees 17
Industries Biotechnology, Manufacturing, Medical Devices +1
Social

Get notified when CONTRAD SWISS moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About CONTRAD SWISS

CONTRAD SWISS is a Swiss-based pharmaceutical corporation dedicated to revolutionizing regenerative medicine. The company's proprietary SIGMOLECS® Technology represents a significant advancement in the use of peptides as active ingredients. Its portfolio includes medical devices and aesthetic products, positioned in the premium segment, offering exceptional value. The technology guides cell behavior for a wide range of treatments, enhancing the penetration of important molecules and utilizing customized peptide sequences. This breakthrough has led to the creation of specialized non-invasive product lines such as 500Line for osteoarthritis and connective tissue pathology, ACTV8 PRO for regenerative aesthetic physicians, and Egyfil for muscle & joint relief. The company is at the forefront of regenerative medicine, aiming to address unmet clinical needs and signaling the future of the industry. Founded in 2011, CONTRAD SWISS operates in the Biotechnology, Manufacturing, Medical Devices, and Pharmaceutical industries.

Taxonomy: Regenerative Medicine, Pharmaceuticals, Peptide Technology, Aesthetic Medicine, Orthopaedics, Non-invasive Therapies, Osteoarthritis Treatment, Connective Tissue Pathology, Muscle & Joint Relief, Regenerative Aesthetics, Chemical Profiling, Biotecnologie, Dermatologia, Pain Management

No funding data available for CONTRAD SWISS yet.

Get notified when CONTRAD SWISS raises funding

CONTRAD SWISS Alternatives & Competitors

CONTRAD SWISS vs

We are the only full-service Regenerative Medicine facility in Knoxville.

2 employees
Health Care, Health and Wellness
CONTRAD SWISS vs
Jointechlabs, Inc.
Jointechlabs, Inc. United States

Advancing Regenerative Medicine at the Point of Care | FDA-Cleared and CE-Marked Devices Transformin...

Series A
8 employees
Biotechnology, Health Care
CONTRAD SWISS vs

Redefining skin regeneration

Seed
21 employees
Biotechnology, Life Sciences

FAQ About CONTRAD SWISS

We are devoted to improving people's life.
CONTRAD SWISS was founded in 2011.
CONTRAD SWISS is headquartered in Lugano, Switzerland.
CONTRAD SWISS operates in the following industries: Biotechnology, Manufacturing, Medical Devices, Pharmaceutical.
CONTRAD SWISS has approximately 17 employees.
Top alternatives and competitors to CONTRAD SWISS include Optimal Health Regenerative Aesthetic Medical, Jointechlabs, Inc., Linio Biotech, Fesarius Therapeutics, Frontier Biologics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
CONTRAD SWISS and Optimal Health Regenerative Aesthetic Medical are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors CONTRAD SWISS and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy